menu ☰
menu ˟

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia

10 Oct 2017

The progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) dementia can be predicted by cognitive, neuroimaging, and cerebrospinal fluid (CSF) markers. Since most biomarkers reveal compleme...

Click here to view the full article which appeared in Alzheimer's Research & Therapy